BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 16522785)

  • 1. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV.
    Maache M; Komurian-Pradel F; Rajoharison A; Perret M; Berland JL; Pouzol S; Bagnaud A; Duverger B; Xu J; Osuna A; Paranhos-BaccalĂ  G
    Clin Vaccine Immunol; 2006 Mar; 13(3):409-14. PubMed ID: 16522785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide.
    Woo PC; Lau SK; Wong BH; Chan KH; Hui WT; Kwan GS; Peiris JS; Couch RB; Yuen KY
    J Clin Microbiol; 2004 Dec; 42(12):5885-8. PubMed ID: 15583332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA.
    Huang LR; Chiu CM; Yeh SH; Huang WH; Hsueh PR; Yang WZ; Yang JY; Su IJ; Chang SC; Chen PJ
    J Med Virol; 2004 Jul; 73(3):338-46. PubMed ID: 15170626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia.
    Woo PC; Lau SK; Wong BH; Tsoi HW; Fung AM; Kao RY; Chan KH; Peiris JS; Yuen KY
    J Clin Microbiol; 2005 Jul; 43(7):3054-8. PubMed ID: 16000415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of IgG antibodies to nucleocapsid and spike proteins of the SARS-associated coronavirus in SARS patients.
    Wang Y; Chang Z; Ouyang J; Wei H; Yang R; Chao Y; Qu J; Wang J; Hung T
    DNA Cell Biol; 2005 Aug; 24(8):521-7. PubMed ID: 16101351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel immunofluorescence assay using recombinant nucleocapsid-spike fusion protein as antigen to detect antibodies against severe acute respiratory syndrome coronavirus.
    He Q; Manopo I; Lu L; Leung BP; Chng HH; Ling AE; Chee LL; Chan SW; Ooi EE; Sin YL; Ang B; Kwang J
    Clin Diagn Lab Immunol; 2005 Feb; 12(2):321-8. PubMed ID: 15699428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Specific antibodies against the nucleocapsid protein and S1 domain of spike glycoprotein in patients with severe acute respiratory syndrome].
    Mei YB; Wang YD; Liao ZY; Hao W; Che XY
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):526-9. PubMed ID: 15949331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.
    van den Brink EN; Ter Meulen J; Cox F; Jongeneelen MA; Thijsse A; Throsby M; Marissen WE; Rood PM; Bakker AB; Gelderblom HR; Martina BE; Osterhaus AD; Preiser W; Doerr HW; de Kruif J; Goudsmit J
    J Virol; 2005 Feb; 79(3):1635-44. PubMed ID: 15650189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins.
    Haynes LM; Miao C; Harcourt JL; Montgomery JM; Le MQ; Dryga SA; Kamrud KI; Rivers B; Babcock GJ; Oliver JB; Comer JA; Reynolds M; Uyeki TM; Bausch D; Ksiazek T; Thomas W; Alterson H; Smith J; Ambrosino DM; Anderson LJ
    Clin Vaccine Immunol; 2007 Mar; 14(3):331-3. PubMed ID: 17229882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination and application of immunodominant regions of SARS coronavirus spike and nucleocapsid proteins recognized by sera from different animal species.
    Yu M; Stevens V; Berry JD; Crameri G; McEachern J; Tu C; Shi Z; Liang G; Weingartl H; Cardosa J; Eaton BT; Wang LF
    J Immunol Methods; 2008 Feb; 331(1-2):1-12. PubMed ID: 18191140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia.
    Woo PC; Lau SK; Tsoi HW; Chan KH; Wong BH; Che XY; Tam VK; Tam SC; Cheng VC; Hung IF; Wong SS; Zheng BJ; Guan Y; Yuen KY
    Lancet; 2004 Mar; 363(9412):841-5. PubMed ID: 15031027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a reference panel for the detection of anti-SARS-CoV antibodies.
    Liu C; Li X; Zhang C; Xu S; Shao Y; Zhuang H; Che X; Qiu Y; Yin H; Li D; Wang Y
    Biologicals; 2007 Jun; 35(3):203-10. PubMed ID: 17261372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody detection of SARS-CoV spike and nucleocapsid protein.
    Chang MS; Lu YT; Ho ST; Wu CC; Wei TY; Chen CJ; Hsu YT; Chu PC; Chen CH; Chu JM; Jan YL; Hung CC; Fan CC; Yang YC
    Biochem Biophys Res Commun; 2004 Feb; 314(4):931-6. PubMed ID: 14751221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative and sensitive detection of the SARS-CoV spike protein using bispecific monoclonal antibody-based enzyme-linked immunoassay.
    Sunwoo HH; Palaniyappan A; Ganguly A; Bhatnagar PK; Das D; El-Kadi AO; Suresh MR
    J Virol Methods; 2013 Jan; 187(1):72-8. PubMed ID: 22995576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein.
    Vlasova AN; Zhang X; Hasoksuz M; Nagesha HS; Haynes LM; Fang Y; Lu S; Saif LJ
    J Virol; 2007 Dec; 81(24):13365-77. PubMed ID: 17913799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibodies against SARS-CoV in serum from SARS-infected donors with ELISA and Western blot.
    Wang YD; Li Y; Xu GB; Dong XY; Yang XA; Feng ZR; Tian C; Chen WF
    Clin Immunol; 2004 Nov; 113(2):145-50. PubMed ID: 15451470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an enzyme-linked immunosorbent assay-based test with a cocktail of nucleocapsid and spike proteins for detection of severe acute respiratory syndrome-associated coronavirus-specific antibody.
    Giménez LG; Rojas J; Rojas A; Mendoza J; Camacho AG
    Clin Vaccine Immunol; 2009 Feb; 16(2):241-5. PubMed ID: 19038782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein.
    Zhong X; Yang H; Guo ZF; Sin WY; Chen W; Xu J; Fu L; Wu J; Mak CK; Cheng CS; Yang Y; Cao S; Wong TY; Lai ST; Xie Y; Guo Z
    J Virol; 2005 Mar; 79(6):3401-8. PubMed ID: 15731234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies.
    Faber M; Lamirande EW; Roberts A; Rice AB; Koprowski H; Dietzschold B; Schnell MJ
    J Gen Virol; 2005 May; 86(Pt 5):1435-1440. PubMed ID: 15831955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cloning, expression, purification and identification of SARS virus S2 gene and study on its immunological characteristics].
    Dong XY; Yang XA; Li Y; Xu GB; Feng ZR; Wang YD; Chen WF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):257-60. PubMed ID: 15193211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.